Additional findings_Adult
Gene: CPS1
Can rarely present in adulthood, including in the postpartum period with coma.
ACMG factsheet relating to management of adults: https://www.acmg.net/PDFLibrary/CPS-I-Deficiency-Transition.pdf.
Management aims to maintain stable metabolic control and to reduce or eliminate chronic complications. Treatment includes medications to promote waste nitrogen excretion (nitrogen scavengers such as sodium benzoate, sodium phenylacetate, sodium phenylbutyrate, and glycerol phenylbutyrate); low-protein diet; and supplementation with arginine or citrulline, essential nutrients, and essential amino acids.
Given the risk of acute metabolic decompensation during surgery and general anaesthesia, elective surgery should only be carried out in centers able and prepared to deal with hyperammonemic decompensations. Specialised management is also required during pregnancy.
Steroids and valproate are to be avoided.
Sources: Expert listCreated: 11 Apr 2025, 6:12 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carbamoylphosphate synthetase I deficiency MIM#237300
Gene: cps1 has been classified as Green List (High Evidence).
Gene: cps1 has been classified as Green List (High Evidence).
gene: CPS1 was added gene: CPS1 was added to Additional findings_Adult. Sources: Expert list Mode of inheritance for gene: CPS1 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CPS1 were set to Carbamoylphosphate synthetase I deficiency MIM#237300 Review for gene: CPS1 was set to GREEN